HomeUNCY • NASDAQ
Unicycive Therapeutics Inc
add
$0.55
3.30%
After Hours:(4.95%)+0.027
$0.57
Closed: Apr 11, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.26M | 46.70% |
Net income | -21.53M | -176.03% |
Net profit margin | — | — |
Earnings per share | -0.26 | -62.50% |
EBITDA | -9.25M | -46.66% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.14M | 169.48% |
Total assets | 31.67M | 123.16% |
Total liabilities | 24.24M | 34.65% |
Total equity | 7.43M | — |
Shares outstanding | 119.71M | — |
Price to book | 7.57 | — |
Return on assets | -65.92% | — |
Return on capital | -125.93% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -21.53M | -176.03% |
Cash from operations | -6.55M | -47.51% |
Cash from investing | -22.00K | — |
Cash from financing | 365.00K | 278.05% |
Net change in cash | -6.21M | -33.61% |
Free cash flow | 9.12M | 1,341.71% |
Previous close
$0.53
Day range
$0.50 - $0.57
Year range
$0.20 - $1.29
Market cap
65.56M USD
Avg Volume
1.08M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Website
Employees
23
